Securities Business Torts Science, Computers & Technology

SEC Class Action Insider Trading Pharmaceutical Industry Fraud Enforcement Actions Securities Fraud FDA Popular Virtual Currency Bitcoin CFTC Cybersecurity Enforcement Investors Life Sciences Clinical Trials Disclosure Requirements Material Nonpublic Information Securities Shareholder Litigation Shareholders Amgen Inc. v Connecticut Retirement Plans Biotechnology Board of Directors Canada Confidential Information Corporate Officers Derivative Suit FinCEN FINRA Fraud-on-the-Market High Frequency Trading Material Misstatements Medical Devices Omnicare Ponzi Scheme Public Offerings Risk Assessment Rule 10b-5 SCOTUS Secondary Markets Securities Act of 1933 Settlement Supreme Court of Canada Acquisitions Activision Administrative Hearings Advancement Algorithmic Trading Amended Regulation Amgen Appeals Attorney-Client Privilege Auditors Audits Australia Australian Securities and Investments Commission Bad Faith Best Management Practices Biopharmaceutical Business Litigation C-Suite Executives Capital Raising CEOs Chief Compliance Officers Citigroup Civil Monetary Penalty Class Certification Cloud Computing Compliance Conflicts of Interest Corporate Governance Corporate Liability Corruption Criminal Prosecution Crowdfunding Cryptocurrency Cumis Counsel Cybersecurity Examination Initiative D&O Insurance Damages Data Breach Data Loss Prevention Data Protection Deficiency Notices Delaware General Corporation Law Directors Discovery Disgorgement Distributors Dodd-Frank DOJ Dole Food Duke Energy Duty of Care Duty of Loyalty Duty to Disclose Ethics Exculpatory Clauses Failure To Disclose False Statements FATF Federal Rules of Civil Procedure Fee-Shifting Forum Shopping Freeze-Out Mergers FSOC FTC Funding Portal G20 Genzyme Healthcare Incident Response Plans Injunctions InterMune Investigations Investor Protection JOBS Act Litigation Fees & Costs Lying Marketing Martoma Mary Jo White Material Disclosures Materiality Mergers Misleading Statements Misrepresentation NFA OCIE Off-Label Promotion Offerings Patent Infringement Permanent Injunctions Personal Liability Policy Exclusions Prejudgment Interest Prescription Drugs PSLRA Publicly-Traded Companies Pyramid Schemes Risk Management Risk Mitigation Rule 26 Sanofi Section 11 Securities Exchange Act Securities Litigation Self-Interest Statement of Opinion Stock Corporations Surveys U.S. Treasury Vendors Websites Whistleblower Awards Whistleblowers Wyndham